The Middle East & Africa diagnostic labs market is expected to grow from US$ 11.39 billion in 2022 to US$ 17.43 billion by 2028. It is estimated to grow at a CAGR of 7.4% from 2022 to 2028.
The health-tech era took off and transformed the healthcare segment to unimaginable levels. Since then, various start-ups have emerged that have revolutionized the industry with innovations such as telemedicine, teleconsultation, and, in particular, diagnostic solutions. Diagnostics labs form the backbone of healthcare.
Technology adoption is essential to meet the increasing consumer demand and have a competitive advantage in the market. In light of this, industry players are harnessing the power of technology to offer new generation healthcare solutions. The technology used in diagnostic labs is rapidly moving toward complete transformation with the help of the latest developments in artificial intelligence (AI) and machine learning (ML).
From developing accurate and efficient diagnostic solutions to adapting to technological interventions, various forward-thinking R&D teams are already working to develop newer and simpler blood analysis and diagnosis methods.
Some developments in the diagnostics lab market are as follows:
In January 2019, Roche launched the Cobas pro integrated solutions in all countries, accepting the CE mark. The product has reset maintenance, efficiency, and reliability standards by increasing patient satisfaction and lowering the cost of healthcare delivery. In February 2020, Ortho Clinical Diagnostics launched a clinical chemistry system that completed its integrated Vitros XT line, designed to cover most typical lab tests. The company estimated its maximum throughput at 755 tests per hour with single-test slides and 1,130 tests per hour with dual-test slides. Moreover, the company's XT 3400 system received CE marking and is available in a few countries in the Middle East & Africa. In September 2021, Ortho Clinical Diagnostics announced the availability of Immediate Spin Crossmatch (ISXM) on the company's Ortho Vision and Ortho Vision Max analyzers to help identify recipient-donor incompatibilities in blood transfusions. Therefore, such developments are projected to boost the market for diagnostics labs in the near future.
With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Middle East & Africa diagnostic labs market growth at a notable CAGR during the forecast period.
Middle East & Africa Diagnostic Labs Market Revenue and Forecast to 2028 (US$ Billion)
Middle East & Africa Diagnostic Labs Market Segmentation
The Middle East & Africa diagnostic labs market is segmented on the basis of lab type, testing services, revenue source, and country. Based on lab type, the market is segmented into single/independent laboratories, hospital-based labs, physician office labs, and others. Based on testing services, the market is divided into physiological function testing, covid-19 testing, general and clinical testing, esoteric testing, specialized testing, non-invasive prenatal testing, and others. By physiological testing services, the market is segmented into ECG, Echo, X-ray, endoscopy, CT, MRI, and others. Based on revenue source, the market is divided into healthcare plan operators and insurers, out-of-pocket, and public systems. Based on country, the regional market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of the MEA.
Middle East & Africa Diagnostic Labs Market —Companies Mentioned
Quest Diagnostics Incorporated; Eurofins Scientific; Exact Sciences Laboratories LLC; SYNLAB International GmbH; Dasa Labs; Bio Reference; Sonic Healthcare Limited; and Healius Limited are a few major companies operating in the Middle East & Africa diagnostic labs market.
Middle East & Africa Diagnostic Labs Market Strategic Insights
Middle East & Africa Diagnostic LabsMarket Report Highlights
| Report Attribute | Details |
| Market size in 2022 | US$ 11.39 Billion |
| Market Size by 2028 | US$ 17.43 Billion |
| CAGR (2022 - 2028) | 7.4% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By Lab Type
|
|
Regions and Countries Covered
|
|
| Middle East and Africa | South Africa, Saudi Arabia, UAE, Rest of Middle East and Africa |
| Market leaders and key company profiles |
|
Middle East & Africa Diagnostic Labs Market Country and Regional Insights
